Submission Details
| 510(k) Number | K251722 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 04, 2025 |
| Decision Date | December 05, 2025 |
| Days to Decision | 184 days |
| Submission Type | Special |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K251722 is an FDA 510(k) clearance for the ProSeal? Transfer Injector (421120, 421130, 421140), a Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System (Class II — Special Controls, product code ONB), submitted by Epic Medical Pte. , Ltd. (Singapore, SG). The FDA issued a Cleared decision on December 5, 2025, 184 days after receiving the submission on June 4, 2025. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5440.
| 510(k) Number | K251722 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 04, 2025 |
| Decision Date | December 05, 2025 |
| Days to Decision | 184 days |
| Submission Type | Special |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | ONB — Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5440 |
| Definition | Reconstitute And Transfer Antineoplastic And Other Hazardous Drugs In Healthcare Setting Indicated To Reduce Exposure Of Healthcare Personnel To Chemotherapy Agents In Healthcare Setting. |